Theradaptive
PrivateLast Round
Series B
Aug 4, 2026
Total Funding Raised
$49.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Theradaptive is a biotechnology company that develops a protein therapeutics platform designed to enable targeted delivery of recombinant proteins for applications in spine, orthopedics, soft tissue repair, and immuno-oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theradaptive Comparables
Compare Theradaptive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RevBio, Inc. | 81% | |
| Locate Bio | 80% | |
| Cerapedics | 80% |
Theradaptive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 4, 2026 | ||||
| Series B | Jan 12, 2026 | ||||
| Grant | Oct 2, 2025 | ||||
| Grant | May 22, 2024 | ||||
| Grant | Sep 26, 2023 | ||||
Grant | Jul 6, 2023 |
Key People
Founding team and executive leadership
Theradaptive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Grant |
| U.S. Department of War | Grant |
| Maryland Stem Cell Research Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 30% MoM, reaching 1.9K.
- Aug 4, 2026
Raised $36.2M in an early stage VC round.
Theradaptive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Theradaptive's valuation, stock price, and market status.
Is Theradaptive a public or private company?
Theradaptive is a private company.
What is the current stock price of Theradaptive?
Theradaptive is a private company with no public stock price. No recent secondary market data is available.
How much is Theradaptive worth (valuation)?
Valuation information for Theradaptive is not publicly available.
Can I buy Theradaptive stock?
Theradaptive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Theradaptive's last funding round?
Theradaptive's most recent funding round was Grant on May 22, 2024.
Who are the main investors in Theradaptive?
Key investors in Theradaptive include TEDCO, U.S. Department of War, Maryland Stem Cell Research Fund.
Will Theradaptive IPO soon?
No public IPO plans have been announced for Theradaptive.
How can I track Theradaptive secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Theradaptive's secondary market activity and sign up for updates.